Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Masked, Dose-Ranging, Multi-Center, Phase II Study Comparing the Safety and Efficacy of OT-551 With Placebo to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration

NCT00485394 is registered in ClinicalTrials.gov with Othera Pharmaceuticals as lead sponsor.

NCT NCT00485394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00485394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Masked, Dose-Ranging, Multi-Center, Phase II Study Comparing the Safety and Efficacy of OT-551 With Placebo to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration
Lead sponsor
Othera Pharmaceuticals
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2007
Completion date
Not reported
Enrollment
198 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration